Clovis Oncology, Inc. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD from Q1 2017 to Q3 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Clovis Oncology, Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q1 2017 to Q3 2022.
- Clovis Oncology, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending September 30, 2022 was $30.7M, a 19.1% decline year-over-year.
- Clovis Oncology, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending September 30, 2022 was $133M, a 14.8% decline year-over-year.
- Clovis Oncology, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $149M, a 9.58% decline from 2020.
- Clovis Oncology, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2020 was $165M, a 15% increase from 2019.
- Clovis Oncology, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2019 was $143M, a 49.9% increase from 2018.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)